Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Dermcidin Mouse anti-Human, Clone: G-81, Novus Biologicals™

Mouse Monoclonal Antibody has been used in 2 publications
Supplier: Novus Biologicals NBP1496200.25ML
Description
Dermcidin Monoclonal specifically detects Dermcidin in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunoassay.Specifications
Dermcidin | |
Monoclonal | |
Unconjugated | |
No buffer with 0.02% Sodium Azide | |
AIDDdiffusible survival/evasion peptide, DCD-1, dermcidin, DSEPpreproteolysin, HCAP, MGC71930, PIF, Preproteolysin, proteolysis inducing factor, survival promoting peptide | |
Mouse | |
Tissue culture supernatant | |
RUO | |
117159 | |
Human | |
Supernatant |
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot, Immunohistochemistry, Immunocytochemistry | |
G-81 | |
Western Blot 1:100-1:2000, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunohistochemistry-Paraffin 1:10-1:500, Immunoassay | |
P81605 | |
DCD | |
Fractioned sweat peptides in complete Freunds adjuvant | |
0.25 mL | |
Primary | |
The monoclonal antibody G-81 was produced against a sweat-specific antigen. It reacts to sweat but not to other body fluids (e.g. serum, saliva, semen, milk, urine and tears) in ELISA. The N-terminal amino acid sequence (18 amino acids residues) is identical to a part of human cachexia-associated protein and of a survival-promoting peptide for neuronal cells. Besides this, the sequence is identical to the C-terminal peptide (amino acids 62-79) of DCD. The monoclonal antibody G81 can be used as a specific marker for eccrine glands in the human skin. | |
Store at 4C. Do not freeze. | |
IgM |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction